The Greater Cannabis Company, Inc. (GCAN) Research

The Greater Cannabis Company, Inc. is dedicated to developing and bringing to market medical treatments that utilize cannabinoids. They feature an innovative oral patch delivery system, designed to efficiently administer active compounds directly into the body via absorption through the inner lining of the mouth. This firm was established in 2014 and is headquartered in Baltimore, Maryland.

Market snapshot

Symbol
GCAN
Price
$0.15
Day change
+1.37%
Market cap
$139.8K
P/E ratio
-1140.97x
52-week range
0.036-0.45
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Advantis Corp. (ADVT)
  • Black Bird Biotech, Inc. (BBBT)
  • CannLabs, Inc. (CANL)
  • Parallel Industries Inc. (EAPH)
  • Green Rain Energy Holdings Inc. (GREH)
  • Item 9 Labs Corp. (INLB)
  • Street Capital Inc. (REZNF)
  • SETO Holdings, Inc. (SETO)

Recent insider activity

  • ZACHARIN AITAN — trade (74166650 shares) on 2018-07-31
  • Sapir LLC — A-Award (100000000 shares) on 2025-04-04
  • Anderson Jimmy Wayne — S-Sale (176878 shares) on 2019-12-02
  • Anderson Jimmy Wayne — S-Sale (195080 shares) on 2019-11-27
  • Anderson Jimmy Wayne — trade (0 shares) on 2019-01-01

Open The Greater Cannabis Company, Inc. (GCAN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.